What Neutroplast does

Neutroplast - Indústria de Embalagens Plásticas S.A. is a privately held Portuguese plastics manufacturer founded in 1993 and headquartered in Sobral de Monte Agraço, Portugal. The company designs and produces primary packaging for regulated industries, principally pharmaceuticals, with secondary application in dermocosmetics, food and nutraceuticals, medical devices, and chemicals. Production runs in ISO 7 and ISO 8 certified clean rooms using three distinct conversion technologies: injection molding, injection-blow molding, and extrusion blow molding, enabling a catalog that spans solid-dose bottles (20-1000ml), liquid containers and droppers (5-1000ml), CE-marked medical measuring devices, and fully custom developments executed through a seven-stage process from requirements evaluation to packaged delivery.

The business operates a direct enterprise field-sales model targeting Purchasing Departments at pharmaceutical, dermocosmetic, nutraceutical, and medical device manufacturers, positioning itself as a consulting partner rather than a transactional supplier. Revenue is generated through hardware sales of catalog and custom packaging, professional services for custom development and tooling, and assembly/ decoration services that translate customer brand identity onto finished products. Pricing is quote-based and undisclosed; larger projects are structured as partnership agreements aligned to project characteristics.

The operating footprint is anchored at a single Portuguese manufacturing site, with export intensity reaching 53.8% by 2018 following an EU FEDER-funded internationalization project (2015-2018). Commercial outreach now extends to North Africa, evidenced by participation in Maghreb Pharma 2026 in Algiers. Quality and regulatory positioning is reinforced by ISO 9001, ISO 13485, ISO 14001, and ISO 15378 certifications (June 2026 audit closed with zero non-conformities), CE marking for medical devices, and an EcoVadis Silver Medal awarded in 2026 placing the company in the top 15% of companies assessed globally. Sustainability investments include a 630-panel photovoltaic installation and a 2026 launch of food-grade PCR HDPE bottles validated up to 30% recycled content, positioning the company ahead of the 2030 PPWR mandate. No external institutional investors or PE/VC backing is disclosed.

Name

Neutroplast

Legal name

Neutroplast - Indústria de Embalagens Plásticas S.A

Website

https://neutroplast.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

51–100 employees

Short description

Neutroplast is a privately held Portuguese manufacturer founded in 1993 that designs and produces certified primary plastic packaging for the pharmaceutical, dermocosmetic, food/nutraceutical, and medical device industries, operating ISO 7 and ISO 8 clean rooms using injection, injection-blow, and extrusion blow molding technologies with direct enterprise sales across international markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Packaging

NAICS

Plastics Product Manufacturing (3261), Plastics Bottle Manufacturing (32616), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Plastics Products, Nec (3089)

akta.pro primary industry

Pharmaceutical & Medical Plastic Packaging Manufacturing (IMANAEAK)

akta.pro secondary industries

Medical & Life Sciences Injection Molding (Devices, Diagnostics, Cleanroom) (IMANAFAC), Packaging Injection Molding (Caps, Closures, Thin-Wall, IML) (IMANAFAA), Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB)

Keywords

• Pharmaceutical packaging
• Primary plastic packaging
• Medical device manufacturing
• Clean room production
• Injection blow molding

Headquarters

HQ city

Sobral De Monte Agraço

HQ country

Portugal

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Primary Packaging Manufacturing and Sales: Manufacturing and sale of primary plastic packaging solutions including solid bottles, liquid containers, droppers, medical devices, and cosmetic packaging. Revenue generated through production volumes, product customization, and distribution capabilities.
2. Custom Packaging Development Services: Customized packaging development services including technical development, prototyping, material selection, color development, printing, and compatibility with automatic production lines. Services are tailored to specific customer requirements for pharmaceutical, cosmetic, and nutraceutical applications.
3. Assembly and Decoration Services: Packaging assembly and decoration services allowing products to reflect customer brand image. Includes mounting and finishing operations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Neutroplast manufactures primary plastic packaging for the pharmaceutical, dermocosmetic, food, and chemical industries. Production uses three technologies — injection, injection-blow, and extrusion blow molding — in ISO 7 and ISO 8 certified clean rooms. The portfolio includes bottles for solids and liquids, CE-marked medical devices, and full custom packaging development services from concept to production.

Product overview

Neutroplast is a European manufacturer of pharmaceutical packaging with over 30 years of experience offering primary packaging solutions for the pharmaceutical, dermocosmetic, food, and chemical sectors. The product portfolio is organized into four main categories: Solids (screw and snap-top bottles for pills and powders from 20ml to 1000ml), Liquids (droppers, PDP dosing bottles, Boston bottles, and cosmetic packaging from 5ml to 1000ml), Medical Devices (CE-marked dosage cups, spoons, and vaginal applicators), and Custom/Tailor-Made Products (full-service development from concept to production). Production is conducted in ISO 7 and ISO 8 certified clean rooms using three distinct technologies: injection, injection-blowing, and blowing. Assembly and decoration services are also offered to reflect brand image. Recent innovation includes the Pill Snap-Top HDPE PCR Food Grade line with 10-30% recycled material content.

Differentiator

Problem solved

Functional benefit

Brands

• BUD: Division offering complementary solutions and custom packaging development
• Digital Product Passport (DPP)

Products and services

• Solid Packaging (Sólidos) Wide selection of bottles for solid formulas and powders with capacities from 20ml to 1000ml, featuring tamper-evident screw and snap-on caps, optional silica gel desiccants, and induction liners.
• Liquid Packaging (Líquidos) Comprehensive range of liquid packaging including droppers, precision dosing pump bottles, syrup bottles, and shampoo bottles with capacities from 5ml to 1000ml, compatible with various closure types including dosing pumps.
• Medical Devices (Dispositivos Médicos) CE-marked medical measuring devices including dosage cups with various graduations (15ml, 20ml, 25ml) and dosage spoons (1.25-5ml, 2.5-5ml), plus vaginal applicators with ergonomic design for precise product application.
• Custom Packaging Development (Produtos à Medida) Full-service custom packaging development from concept to production, including technical development, prototyping, material selection, color development, printing, compatibility testing with automatic lines, and production in ISO 7 and ISO 8 clean rooms.
• Pill Snap Top Series Snap-top bottles for solid formulas and supplements, available in 75ml, 85ml, 100ml, 125ml, 200ml, and 350ml capacities, also offered with 10-30% Food Grade PCR HDPE material.
• Pill Screw Series Screw-cap bottles for solid formulas and powders with capacities ranging from 30ml to 350ml, with optional silica gel desiccants for moisture protection.
• Pill Triangular Series Triangular-shaped bottles for solid formulas, available in 25ml, 36ml, and 60ml capacities with optional silica gel desiccants.
• Iodopovidona Dropper Specialized dropper bottle for iodopovidone solutions in 125ml capacity with dedicated iodopovidone cap and dropper options.
• PDP Series (Pharmaceutical Dosage Bottle) Precision dosage bottles available in screw and snap variants, with capacities from 12ml to 100ml and various adapters (auricular, nasal, oral, topical).
• Cosmetic Packaging Series Cosmetic bottles and overcaps including D20, 18/415, 24/415 neck finishes, standard bottles, and overcap closures, with capacities ranging from 12ml to 1000ml.
• Dropper Series Dropper bottles in round and square configurations, with round droppers from 5ml to 125ml and square droppers from 30ml to 50ml.
• Pill Snap-Top HDPE PCR Food Grade Line Snap-top bottles incorporating 10% Food-Grade PCR (Post-Consumer Recycled) HDPE material, with validated solutions up to 30% PCR, compliant with PPWR regulation for food supplements packaging from 2030.

Quantifiable outcome

• Zero non-conformities in 2026 external audit maintaining ISO 9001, ISO 14001, and ISO 15378 certifications
• +2 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Alpla Group: Austrian-headquartered global plastics packaging specialist (injection molding, blow molding, extrusion) with healthcare packaging offerings. Comparable molding technologies and European manufacturing footprint, though serving a much broader customer base beyond pharma.
• Becton, Dickinson and Company (BD): Global medical technology giant whose Medical segment includes drug delivery devices and pharmaceutical systems. Overlaps with Neutroplast on CE-marked dosing devices and primary-container-adjacent products, though at far broader scale and scope.
• Berry Global Group, Inc. Large global plastics packaging manufacturer with a healthcare division producing pharma bottles, closures, and medical films. Overlaps with Neutroplast on plastic primary packaging formats and injection/blow-molding capabilities, but as part of a much broader portfolio.

Direct peers

• Stevanato Group S.p.A. Italian-headquartered supplier of glass primary packaging and integrated drug delivery / device solutions. Directly comparable in regulated pharma primary packaging and CE-marked device components, including vials, syringes, and dosing systems.
• West Pharmaceutical Services, Inc. Global leader in elastomeric closures, seals, and primary packaging components for injectable drug delivery. Comparable in pharma primary-packaging component supply, clean-room manufacturing, and ISO certifications.
• AptarGroup, Inc. US-listed leader in dispensing systems and active material science solutions for pharma, beauty, and food. Overlaps directly with Neutroplast on pharmaceutical droppers, pumps, and closures, with comparable regulated-industry customer base and certifications.
• Gerresheimer AG: Global German-headquartered manufacturer of primary pharmaceutical packaging (bottles, vials, ampoules, syringes, droppers) and drug delivery devices. Directly comparable in product categories (solid and liquid primary packaging), target customers (pharma manufacturers), and regulatory certifications (ISO 15378-equivalent GMP).
• Nipro Corporation: Japanese-headquartered medical device and pharmaceutical packaging manufacturer producing vials, ampoules, and prefillable systems. Comparable in primary-container supply to pharma manufacturers and CE/ISO regulatory positioning.
• DWK Life Sciences GmbH: European-headquartered manufacturer of laboratory and pharmaceutical primary packaging (bottles, droppers, vials). Directly comparable in European pharmaceutical primary-container supply and CE/ISO positioning, though with glass-heavy product mix.
• SCHOTT Pharma AG & Co. KGaA: Specialist in primary pharmaceutical packaging (vials, syringes, cartridges, ampoules). While glass-focused, its primary-packaging focus, ISO/GMP certifications, and pharma customer overlap make it a direct comparable for primary-container supply relationships.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neutroplast